Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection

Clinical and Experimental Rheumatology

Volumn 31, Issue 1, 2013, Pages 84-90

  Jeon, You La ^a   Kim, Myeong Hee ^a   Lee, Woo In ^a   Kang, So Young ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Autoantibody; Indirect immunofluorescence; Line immunoassay; Sensitivity; Systemic autoimmune disease

Indexed keywords

AUTOANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL EVALUATION; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LINE IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOASSAY; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; SENSITIVITY AND SPECIFICITY;

EID: 84874846579     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. GHIRARDELLO A, VILLALTA D, MOROZZI G et al.: Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 2011; 29: 50-6.
2. WIIK AS, HØIER-MADSEN M, FORSLID J, CHARLES P, MEYROWITSCH J: Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010; 35: 276-90.
3. CASTRO C, GOURLEY M: Diagnostic testing and interpretation of tests for autoimmunity. J Allergy Clin Immunol 2010; 125: S238-47.
4. MERONI PL, SCHUR PH: ANA screening: an old test with new recommendations. Ann Rheum Dis 2010; 69: 1420-2.
5. AKSU G, GULEZ N, AZARSIZ E, KARACA N, KUTUKÇULER N: Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children. J Clin Lab Anal 2010; 24: 230-6.
6. FELTKAMP TE: Antinuclear antibody determination in a routine laboratory. Ann Rheum Dis 1996; 55: 723-7.
7. GREIDINGER E, HOFFMAN R: Antinuclear antibody testing: methods, indications, and interpretation. Lab Med 2003; 34: 113-8.
8. BIZZARO N, TOZZOLI R, TONUTTI E et al.: Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Methods 1998; 219: 99-107.
9. MAHLER M, HANLY JG, FRITZLER MJ: Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2012; 11: 642-5.
10. SHANMUGAM VK, SWISTOWSKI DR, SADDIC N, WANG H, STEEN VD: Comparison of indirect immunofluorescence and multiplex sclerosis. Clin Rheumatol 2011; 30: 1363-8.
11. COLGLAZIER CL, SUTEJ PG: Laboratory testing in Rheumatic diseases: a practical review. South Med J 2005; 98: 185-91.
12. BURBELO PD, CHING KH, HAN BL, BUSH ER, REEVES WH, IADAROLA MJ: Extraordinary antigenicity of the human Ro-52 autoantigen. Am J Trans Res 2010; 2: 145-55.
13. RUTJES SA, VREENEQBERTS WT, JONGEN P, VAN DEN HOOGEN F, PRUIJN GJ, VAN VENROOIJ WJ: Anti-Ro52 antibodies frequently co-occur with anti-Jo1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32-40.
14. HERVIER B, RIMBERT M, COLONNA F, HAMIDOU MA, AUDRAIN M: Clinical significance of anti-Ro/SSA-52 kDa antibodies: a retrospective monocentric study. Rheumatology 2009; 48: 964-7.
15. METSKÜLA K, SALUR L, MANDEL M, UIBO R: Demonstration of high prevalence of SS-A antibodies in a general population: Association with HLA-DR and enterovirus antibodies. Immunol Lett 2006; 106: 14-8.
16. LÓPEZ-HOYOS M, RODRÍGUEZ-VALVERDE V, MARTINEZ-TABOADA V: Performance of antinuclear antibody connective tissue disease screen. Ann N Y Acad Sci 2007; 1109: 322-9.